Silence Therapeutics plc Logo

Silence Therapeutics plc

Clinical-stage biotech developing siRNA medicines to silence disease-causing genes.

SLN | US

Overview

Corporate Details

ISIN(s):
US82686Q1013 (+1 more)
LEI:
Country:
United States of America
Address:
12 HAMMERSMITH GROVE, LONDON

Description

Silence Therapeutics plc is a clinical-stage biotechnology company pioneering the design and development of medicines based on short-interfering RNA (siRNA). The company utilizes its proprietary technology platform to create precision-engineered therapies that selectively silence the expression of disease-causing genes. Its clinical pipeline focuses on addressing conditions with high unmet medical needs in therapeutic areas such as cardiovascular disease, hematology, and rare diseases. Key product candidates in development include zerlasiran, targeting cardiovascular risk, and divesiran for polycythemia vera. The company aims to provide transformative treatments for patients who have limited or inadequate therapeutic options.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-06 22:15 English ZIP 7.1 KB
2026-01-06 22:15 English ZIP 7.0 KB
2026-01-06 22:15 English ZIP 7.3 KB
2026-01-06 22:15 English ZIP 7.3 KB
2026-01-06 22:15 English ZIP 7.2 KB
2025-12-23 00:04 English ZIP 7.2 KB
2025-12-23 00:03 English ZIP 7.1 KB
2025-12-23 00:02 English ZIP 10.6 KB
2025-12-22 22:01
8-K/A
English ZIP 65.9 KB
2025-12-22 13:32
8-K
English ZIP 62.4 KB
2025-12-15 22:01
8-K
English ZIP 80.0 KB
2025-11-06 13:53
10-Q
English ZIP 1.1 MB
2025-11-06 13:38
8-K
English ZIP 130.7 KB
2025-10-23 13:45
8-K
English ZIP 81.1 KB
2025-08-14 12:30
8-K
English ZIP 61.6 KB

Automate Your Workflow. Get a real-time feed of all Silence Therapeutics plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Silence Therapeutics plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Silence Therapeutics plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.